Smile Invest Joins Medtech Company MedEnvision

Smile Invest has joined forces with MedEnvision, a leading medtech company, acquiring a 50% stake in the business. With the support of this investment fund, MedEnvision aims to accelerate its international growth.

MedEnvision develops innovative instruments that assist surgeons and medical staff during hip, knee, and shoulder surgeries. The company takes pride in its solutions, which streamline operations by freeing up time and resources for critical tasks in the operating room. Additionally, MedEnvision’s instruments provide surgeons with enhanced control during procedures. Founded in 2011 in Westerlo, Belgium, MedEnvision originated from a collaboration between surgeon Kristoff Corten and the design and engineering firm Comate, in which investor Marc Coucke later became involved.

MedEnvision primarily serves hospitals, with its solutions available in 26 countries. The company generated €12 million in revenue last year, marking a 50% increase. Its strongest market presence is in the Benelux region and the United States.

With Smile Invest as a new partner, MedEnvision seeks to expand its international footprint and develop new products. The investment firm now holds half of MedEnvision’s shares, while the remaining shares are retained by the company’s founders and management team.

Including MedEnvision, Smile Invest currently has a portfolio of 15 companies. The firm has already completed three successful exits: Climate For Life, Smart SD (with reinvestment), and Microflor. Established in 2017 by Urbain Vandeurzen, the former founder and CEO of technology company LMS, Smile Invest raised €350 million from a select group of Flemish and Dutch entrepreneurial families.

Source: De Tijd, Michaël Sephiha, 1/03/2024, This is an automatically generated translation of the original article, Link to original article.